Watch webinars on Evercode™ technology and its applications.
Single Cell RNA Sequencing (scRNA-seq) is helping researchers uncover new insights in ways not possible with traditional bulk RNA sequencing methods. For researchers interested in learning more or just getting started, we’ve developed a series of three educational webinars focused on demystifying scRNA-seq.
In our first webinar of the series, we explored scRNA-seq’s origins and what research questions it can help you answer.
In this webinar, Federico Gaiti, PhD, from Princess Margaret Cancer Centre, presents information on spatial intra-tumoral heterogeneity of malignant and immune cells in glioblastoma and how the Parse technology is helping Dr. Gaiti’s team advance their work and knowledge in GBM.
In this webinar, Narges Rezaie, a PhD candidate from the University of California, Irvine, demonstrates how to use topic modeling to identify repeated patterns in single cell data.
During the webinar, Dr. Cong and Yuanhao (Jerry) Qu discussed the advancements made possible by CRISPR Detect. They discuss a new single-cell “perturb and trace” system that combines multiplexed Cas12a perturbations with a machine learning-optimized, single-cell evolvable barcoding system.
In this webinar, Dr. Swarup, demonstrates the protective functions of microglia in reducing CAA, blood-brain barrier dysfunction, and brain calcification. Examination of human AD tissue and iPSC-microglia demonstrates that microglia phagocytose calcium crystals and is impaired by the loss of the AD risk gene, TREM2.
Glioblastoma remains the most common form of brain cancer, exhibiting enormous heterogeneity in the tumor and immune compartments within both the same tumor and between patients. To characterize this heterogeneity within tumor samples and in vitro models, we utilized the Parse Evercode V2 assay to profile whole cells processed from a patient-derived neurosphere line alongside nuclei isolated from a piece of flash-frozen glioblastoma tissue.
This session is part of Parse Biosciences’ 2023 Brain Awareness Month.
With flexible and scalable solutions available, learn why single-cell sequencing studies are no longer out of reach. Watch the webinar recording where our speaker, Dr. Benjamin Ostendorf, Charité-Universitätsmedizin, Berlin, presents the results of his recent single-cell study, published Sep 2022 in the Journal Nature, on the role of APOE in Murine COVID-19 mortality.
In this webinar, you will learn about Evercode TCR for immune profiling and Gene Capture for even greater scalability. You will also learn more about Parse’s foundational technology platform, which enables single cell RNA sequencing with no microfluidics instrument required.
In this webinar, Dr. Katerina Gurova, Roswell Park Cancer Institute, describes how she used scRNA-Seq to examine whether the transition between one epigenetic state into another makes cells vulnerable to oncogene induced transformation.
The gene-regulatory landscape of the brain is highly dynamic in health and disease, coordinating a menagerie of biological processes across distinct cell types. Understanding these regulatory programs requires a holistic experimental and analytical approach. Here, we present a single-cell study of 380,000 nuclei in late-stage Alzheimer’s Disease (AD) using parse biosciences whole transcriptome kit, profiling gene expression in thousands of genes and uncovering vast neuronal and glial heterogeneity in late-stage AD.
The average number of cells profiled in single cell RNA sequencing (scRNA-Seq) experiments has doubled each year since 2015. Yet traditional scRNA-Seq technologies have not scaled well nor do they provide straightforward implementation. Join us for a webinar with Parse Biosciences CTO, Charlie Roco. In it, he describes how straightforward it is to get started and scale with Parse’s combinatorial barcoding technology, Evercode.
During the webinar, Dr. Cong and Yuanhao (Jerry) Qu discussed the advancements made possible by CRISPR Detect. They discuss a new single-cell “perturb and trace” system that combines multiplexed Cas12a perturbations with a machine learning-optimized, single-cell evolvable barcoding system.
In the evolving field of single cell transcriptomics, selecting the right technology is crucial for meaningful discoveries. Using paired biological samples, we conducted a comparative analysis of Parse and other technologies to examine the strengths and limitations of different single-cell methods.
Type 2 diabetes (T2D) is a known risk factor for cerebrovascular diseases including Alzheimer’s disease (AD), and vascular dementia (VaD). Yet, our understanding of the mechanisms whereby T2D contributes to neurodegeneration and VaD remains poorly defined. In this study, we utilized the db/db murine model of T2D and single nuclei RNA sequencing to determine the effect of T2D on endothelial cell-specific transcriptomic changes in the hippocampus, an important brain memory center.
Type 2 diabetes (T2D) is a known risk factor for cerebrovascular diseases including Alzheimer’s disease (AD), and vascular dementia (VaD). Yet, our understanding of the mechanisms whereby T2D contributes to neurodegeneration and VaD remains poorly defined. In this present work, we utilized the db/db murine model of T2D and single nuclei RNA sequencing to determine the effect of T2D on endothelial cell-specific transcriptomic changes in the hippocampus, an important brain memory center.
In this session, Jose Jacob, Senior Product Manager from Parse Biosciences, discusses the latest product release, Transgenic Mouse BCR kit, which offers a streamlined and fully-optimized high throughput single cell BCR screening solution to help fast-track antibody discovery efforts.
While high throughput sequencing methods have facilitated the discovery and characterization of various cell types, sequencing costs can be prohibitively high for routine use. Many applications of scRNA-seq are focused on cell type identification, gene regulatory networks, or biomarker discovery. These applications often do not require surveying the entire transcriptome, but rather require the interrogation of specific sets of well-characterized genes. In these cases, sequencing the entire transcriptome may be adding unnecessary project costs. To increase throughput and minimize sequencing costs, the development of a targeted gene enrichment method is
required.
Join us for an informative webinar in which Parse Biosciences CTO, Charlie Roco, discusses the discovery power of Evercode WT Penta. By attending, you will: Learn about Evercode split-pool combinatorial barcoding as the leading choice for single cell research; See why scale is important in single cell studies and what this product can mean for your research; Evaluate the dataset presented during the webinar, showcasing 5 million cells in a single run.
In our CoLab session, Chief Technology Officer Charlie Roco, PhD, unveils exciting updates to our portfolio of single cell solutions. Highlights include advancements in Evercode Whole Transcriptome, Evercode TCR, Evercode BCR, and Trailmaker, all designed to make single cell more accessible and powerful than ever.
Uncovering the full diversity of B cell repertoires is key to understanding immunological disease and driving efficient antibody discovery campaigns. Parse Evercode™ BCR bolsters such efforts through simultaneous profiling full-length BCR sequences and the whole transcriptome with single cell resolution. In this presentation, we highlight several exciting antibody discovery applications of Evercode BCR.
In the evolving field of single cell transcriptomics, selecting the right technology is crucial for meaningful discoveries. Using paired biological samples, we conducted a comparative analysis of Parse and other technologies to examine the strengths and limitations of different single-cell methods.
In this session, Elisabeth Rebboah, PhD, from the Mortazavi Lab at UC Irvine, discusses her recent work on the impact of genetic diversity on cell type- and state-specific gene expression in mice.
What you’ll learn:
What you’ll learn:
In this webinar, Robert Lochhead from the Medical College of Wisconsin, explains his use of the Parse single cell RNAseq and other downstream in vitro validation methods, showing that IFN-gamma-stimulated fibroblast-like synoviocytes are inducible APCs.
What you’ll learn:
In this webinar, Ethan Goodman explains how single-cell sequencing was used to identify the key cells and critical signaling pathways in the brain responsible for a heightened fear response due to social stress in mice, providing insights into the molecular mechanisms underlying stress-related behavioral changes.
Join us for an informative webinar in which we overview our new single cell BCR and TCR profiling products which enable immune profiling at unprecedented scale. We are also excited to showcase the work of the Reticker-Flynn Lab at Stanford and how they are using single cell immune profiling to understand the process by which tumors evade the immune system and metastasize to invade the body.
The average number of cells profiled in single cell RNA sequencing (scRNA-Seq) experiments has doubled each year since 2015. Yet traditional scRNA-Seq technologies have not scaled well nor do they provide straightforward implementation. Join us for a webinar with Parse Biosciences CTO, Charlie Roco. In it, he describes how straightforward it is to get started and scale with Parse’s combinatorial barcoding technology, Evercode.
Single cell RNA sequencing has become a core tool for researchers to understand biology. As scRNA-seq has become more ubiquitous, many applications demand higher scalability and sensitivity. To meet this need, we developed the Evercode Whole Transcriptome v2 solution, a combinatorial barcoding workflow for scRNA-seq with dramatically improved sensitivity, robustness, and unbiased gene expression.
What you’ll learn:
What you’ll learn:
What you’ll learn:
What you’ll learn:
What you’ll learn:
What you’ll learn:
What you’ll learn:
Single Cell RNA Sequencing (scRNA-seq) is helping researchers uncover new insights in ways not possible with traditional bulk RNA sequencing methods. For researchers interested in learning more or just getting started, we’ve developed a series of three educational webinars focused on demystifying scRNA-seq.
In our third and final webinar in the series, we described unique considerations for sequencing and data analysis when doing scRNA-seq experiments.
Single Cell RNA Sequencing (scRNA-seq) is helping researchers uncover new insights in ways not possible with traditional bulk RNA sequencing methods. For researchers interested in learning more or just getting started, we’ve developed a series of three educational webinars focused on demystifying scRNA-seq.
In our second webinar of the series, we described unique considerations for experimental design and sample preparation when doing scRNA-seq projects.
Single Cell RNA Sequencing (scRNA-seq) is helping researchers uncover new insights in ways not possible with traditional bulk RNA sequencing methods. For researchers interested in learning more or just getting started, we’ve developed a series of three educational webinars focused on demystifying scRNA-seq.
In our first webinar of the series, we explored scRNA-seq’s origins and what research questions it can help you answer.